| Identification | |
| Name: | Bezafibrate |
| Synonyms: | Bezatol SR;LO 44;2-(p-(2-(p-Chlorobenzamido)ethyl)phenoxy)-2-methylpropionic acid;Bezalip;Prestwick_724;BF-759;Cedur;2-[4-[2-[(4-chlorobenzoyl)amino]ethyl]phenoxy]-2-methyl-propanoic acid;2-{4-[2-(4-chlorobenzamido)ethyl]phenoxy}-2-methylpropanoic acid;BM 15075;Propionic acid, 2-(4-(2-((4-chlorobenzoyl)amino)ethyl)phenoxy)-2-methyl-; |
| CAS: | 41859-67-0 |
| EINECS: | 255-567-9 |
| Molecular Formula: | C19H20ClNO4 |
| Molecular Weight: | 361.8194 |
| InChI: | InChI=1S/C19H20ClNO4/c1-19(2,18(23)24)25-16-9-3-13(4-10-16)11-12-21-17(22)14-5-7-15(20)8-6-14/h3-10H,11-12H2,1-2H3,(H,21,22)(H,23,24) |
| Molecular Structure: |  |
| Properties | |
| Density: | 1.26 g/cm3 |
| Stability: | Stable at normal temperatures and pressures. |
| Refractive index: | 1.583 |
| Water Solubility: | DMF: soluble |
| Solubility: | DMF: soluble |
| Appearance: | solid |
| Specification: |
?Bezafibrate (CAS NO.41859-67-0) is one of the popular medicines available in today's medical field, which is very much effective against various diseases that affect human body. This medicine is one of the fast effective drugs included under the category, fibrate drug using in the medical field for treating the disease of hyperlipidaemia. Lowering the triglyceride and LDL cholesterol level in human blood and increasing the HDL level is the main functioning of this medicine. Boehringer Mannheim introduced the Bezafibrate - Canadian drug in the year 1977 as a valuable contribution to the medical field. |
| Storage Temperature: | Keep tightly closed. |
| Usage: | Antilipemic |
| Safety Data | |
| Hazard Symbols |
Xn:Harmful
|
 |
|
